Enhancing the Function of the Proofreader in Colorectal Cancer Stem Cells Using CRISPR Techniques

Evan Liu

Kang Chiao International School, China.

Volume 2025 · December 28, 2025 · pp. 166–173

Download article PDF
DOI: https://doi.org/10.55574/wdux6244

Abstract

Colorectal cancer (CRC) is one of the most prevalent malignancies worldwide. Colorectal cancer stem cells (CCSCs) play a significant role in the development of therapeutic resistance and recurrence of the cancer. These cells exhibit self-renewal and pluripotency, which makes them resistant to conventional treatments. The deficiencies in DNA proofreading—particularly the exonuclease activity of DNA polymerases—might lead to a higher probability of mutations and genomic instability. This conceptual paper proposes a novel prior prevention of colorectal cancer that combines CRISPR-Cas9 gene-editing technology with enhanced DNA proofreading capacity in CCSCs. By using CRISPR to either correct mutations in exonuclease domains or fuse high-fidelity polymerases with genome-editing tools, we can potentially reduce the probability of mutation and improve therapeutic outcomes. We discuss the background, proposed methodology, possible results, and implications, integrating insights from recent single-cell RNA sequencing studies and gene therapy trials.

Keywords DNA Polymerases; CRISPR-Cas9; Cancer Stem Cells

The volume copyright notice sets out the author’s rights and the CC BY 4.0 license.